AG˹ٷ

STOCK TITAN

[424B2] Morgan Stanley Prospectus Supplement

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
424B2
Rhea-AI Filing Summary

Transaction overview. UBS AG is marketing Capped Market-Linked Notes due 5 Nov 2026 that are unsecured senior debt securities of the London branch. The notes are linked to the least-performing of three major U.S. equity indices—the Nasdaq-100 (NDX), Russell 2000 (RTY) and S&P 500 (SPX)—and have an expected 15-month tenor (trade date 1 Aug 2025; maturity 5 Nov 2026).

Return profile. � Principal amount: US$1,000 per note.
� Upside: investors receive the lesser of the positive performance of the worst index and a fixed Maximum Gain of 11.75 %, producing a maximum payment of $1,117.50.
� Downside: if the worst index is flat or negative, repayment is limited to principal—no additional return.
No periodic coupons; all cash flow is received at maturity.
� Performance is assessed only once, on the 2 Nov 2026 final valuation date.

Risk considerations. The notes are subject to UBS� credit risk; they are neither FDIC-insured nor secured. Liquidity is expected to be limited: the securities will not be listed and secondary market making by UBS Securities LLC is discretionary. The estimated initial value is expected to be 96.23 %�99.23 % of face, reflecting a $2.50 underwriting discount, hedging costs and UBS� internal funding rate. Investors face correlation risk because the payoff depends on the worst performer; positive moves in two indices are ignored if one index underperforms.

Key dates. Settlement is scheduled for 6 Aug 2025 (T+3). Because U.S. secondary trades shift to T+1, early trades may require special settlement arrangements. Principal protection applies only if the notes are held to maturity.

Target investors. The suitability section emphasises buyers who: (i) seek capped equity exposure with full principal repayment; (ii) can tolerate interim price volatility; (iii) do not need current income; and (iv) are comfortable bearing UBS credit risk.

Deal economics. UBS Securities LLC acts as underwriter, earning the $2.50 per-note discount and may re-allow it to third-party dealers. Following issuance, UBS� bid may temporarily exceed model value by up to the embedded sales concessions, which amortise to zero within six months.

Material legal & tax items. The SEC-registered 424B2 supplement incorporates the Feb-2025 base prospectus, index supplement and product supplement. For U.S. tax purposes, the notes are expected to be treated as contingent payment debt instruments, requiring OID accrual; investors should review the detailed CPDI discussion and consult advisers.

Panoramica della transazione. UBS AG sta promuovendo Note Capped Market-Linked con scadenza il 5 novembre 2026, che sono titoli di debito senior non garantiti della filiale di Londra. Le note sono collegate al peggior rendimento tra tre principali indici azionari statunitensi: Nasdaq-100 (NDX), Russell 2000 (RTY) e S&P 500 (SPX), con una durata prevista di 15 mesi (data di negoziazione 1 agosto 2025; scadenza 5 novembre 2026).

Profilo di rendimento. � Importo nominale: 1.000 USD per nota.
� Potenziale guadagno: gli investitori ricevono il minore tra la performance positiva dell'indice peggiore e un Guadagno Massimo dell'11,75%, con un pagamento massimo di 1.117,50 USD.
� Rischio di perdita: se l'indice peggiore è stabile o negativo, il rimborso è limitato al capitale investito, senza ulteriori rendimenti.
Nessuna cedola periodica; tutti i flussi di cassa vengono corrisposti alla scadenza.
� La performance viene valutata una sola volta, alla data finale del 2 novembre 2026.

Considerazioni sui rischi. Le note sono soggette al rischio di credito di UBS; non sono assicurate dalla FDIC né garantite. La liquidità potrebbe essere limitata: i titoli non saranno quotati e la negoziazione sul mercato secondario da parte di UBS Securities LLC è discrezionale. Il valore iniziale stimato è previsto tra il 96,23% e il 99,23% del valore nominale, considerando uno sconto di sottoscrizione di 2,50 USD, costi di copertura e il tasso interno di finanziamento di UBS. Gli investitori affrontano un rischio di correlazione poiché il rendimento dipende dall'indice peggiore; eventuali movimenti positivi degli altri due indici sono ignorati se uno risulta sottoperformante.

Date chiave. Il regolamento è previsto per il 6 agosto 2025 (T+3). Poiché le negoziazioni secondarie negli USA passano a T+1, le operazioni anticipate potrebbero richiedere accordi di regolamento speciali. La protezione del capitale si applica solo se le note sono detenute fino alla scadenza.

Investitori target. La sezione di idoneità sottolinea gli acquirenti che: (i) cercano un'esposizione azionaria con limite massimo e rimborso completo del capitale; (ii) possono tollerare la volatilità dei prezzi nel breve termine; (iii) non necessitano di reddito corrente; e (iv) sono disposti a sostenere il rischio di credito di UBS.

Economia dell'operazione. UBS Securities LLC agisce come sottoscrittore, guadagnando uno sconto di 2,50 USD per nota, che può essere riconosciuto a rivenditori terzi. Dopo l'emissione, il prezzo di acquisto offerto da UBS può temporaneamente superare il valore teorico fino alle commissioni di vendita incorporate, che si ammortizzano a zero entro sei mesi.

Aspetti legali e fiscali rilevanti. Il supplemento 424B2 registrato presso la SEC incorpora il prospetto base di febbraio 2025, il supplemento indici e il supplemento prodotto. Ai fini fiscali statunitensi, le note sono considerate strumenti di debito con pagamento condizionato, richiedendo l'accumulo di OID; gli investitori dovrebbero esaminare la dettagliata discussione CPDI e consultare i propri consulenti.

Resumen de la transacción. UBS AG está promocionando Notas Vinculadas al Mercado con Límite Máximo con vencimiento el 5 de noviembre de 2026, que son valores de deuda senior no garantizados de la sucursal de Londres. Las notas están vinculadas al rendimiento más bajo de tres índices bursátiles estadounidenses principales: Nasdaq-100 (NDX), Russell 2000 (RTY) y S&P 500 (SPX), con un plazo esperado de 15 meses (fecha de operación 1 de agosto de 2025; vencimiento 5 de noviembre de 2026).

Perfil de rendimiento. � Importe nominal: 1,000 USD por nota.
� Potencial de ganancia: los inversores reciben el menor entre el rendimiento positivo del índice con peor desempeño y una Ganancia Máxima del 11.75%, con un pago máximo de 1,117.50 USD.
� Riesgo a la baja: si el índice peor está plano o negativo, el reembolso se limita al capital, sin rendimiento adicional.
No hay cupones periódicos; todos los flujos de efectivo se reciben al vencimiento.
� La valoración del rendimiento se realiza una sola vez, en la fecha final del 2 de noviembre de 2026.

Consideraciones de riesgo. Las notas están sujetas al riesgo crediticio de UBS; no están aseguradas por la FDIC ni garantizadas. Se espera que la liquidez sea limitada: los valores no estarán listados y la creación de mercado secundaria por UBS Securities LLC es discrecional. El valor inicial estimado se espera entre 96.23% y 99.23% del valor nominal, reflejando un descuento de suscripción de 2.50 USD, costos de cobertura y la tasa interna de financiamiento de UBS. Los inversores enfrentan riesgo de correlación porque el pago depende del peor índice; se ignoran los movimientos positivos de dos índices si uno tiene un desempeño inferior.

Fechas clave. La liquidación está programada para el 6 de agosto de 2025 (T+3). Debido a que las operaciones secundarias en EE.UU. cambian a T+1, las operaciones anticipadas pueden requerir arreglos especiales de liquidación. La protección del capital se aplica solo si las notas se mantienen hasta el vencimiento.

Inversores objetivo. La sección de idoneidad enfatiza a compradores que: (i) buscan exposición accionaria limitada con reembolso total del capital; (ii) pueden tolerar la volatilidad temporal del precio; (iii) no necesitan ingresos actuales; y (iv) están cómodos asumiendo el riesgo crediticio de UBS.

Economía de la operación. UBS Securities LLC actúa como suscriptor, ganando un descuento de 2.50 USD por nota, que puede ceder a distribuidores terceros. Tras la emisión, la oferta de UBS puede superar temporalmente el valor modelo hasta las concesiones de venta incorporadas, que se amortizan a cero en seis meses.

Aspectos legales y fiscales importantes. El suplemento 424B2 registrado en la SEC incorpora el prospecto base de febrero de 2025, el suplemento de índices y el suplemento del producto. Para fines fiscales en EE.UU., se espera que las notas se traten como instrumentos de deuda con pago contingente, requiriendo acumulación de OID; los inversores deben revisar la discusión detallada sobre CPDI y consultar asesores.

거래 개요. UBS AG� 2026� 11� 5� 만기� 상한선이 설정� 시장 연계 노트(Capped Market-Linked Notes)� 런던 지점의 무담� 선순� 채무 증권으로� 판매하고 있습니다. � 노트� 미국� 주요 3� 주가지� � 최저 성과 지�� 나스�-100(NDX), 러셀 2000(RTY), S&P 500(SPX)� 연동되며, 예상 만기 기간은 15개월입니�(거래� 2025� 8� 1�; 만기 2026� 11� 5�).

수익 구조. � 원금 금액: 노트� 미화 1,000달러.
� 상승 가능성: 투자자는 최저 성과 지수의 양의 수익률과 고정� 최대 수익� 11.75%� 낮은 수익� 받아 최대 지급액은 1,117.50달러입니�.
� 하락 위험: 최저 성과 지수가 변� 없거� 마이너스� 경우, 상환은 원금 한도� 제한되며 추가 수익은 없습니다.
정기 쿠폰 없음; 모든 현금 흐름은 만기� 지급됩니다.
� 성과 평가� 2026� 11� 2� 최종 평가일에 � � � 이루어집니다.

위험 고려 사항. � 노트� UBS� 신용 위험� 노출되어 있으�, FDIC 보험 적용 대상이 아니� 담보� 없습니다. 유동성은 제한적일 것으� 예상되며, 증권은 상장되지 않고 UBS Securities LLC� 2� 시장 조성은 재량� 따릅니다. 초기 예상 가�� 액면가� 96.23%~99.23% 사이�, 2.50달러� 인수 수수�, 헤지 비용 � UBS 내부 자금 조달 비용� 반영합니�. 투자자는 수익� 최저 성과 지수에 따라 결정되므� 상관관� 위험� 노출되며, � 지수가 저조하� 다른 � 지수의 긍정� 움직임은 무시됩니�.

주요 일정. 결제� 2025� 8� 6�(T+3)� 예정되어 있습니다. 미국 2� 거래가 T+1� 변경됨� 따라 조기 거래� 특별 결제 조정� 필요� � 있습니다. 원금 보호� 노트� 만기까지 보유� 경우에만 적용됩니�.

대� 투자�. 적합� 섹션은 다음� 같은 투자자를 강조합니�: (i) 최대 수익 한도가 있는 주식 노출� 원금 전액 상환� 원하� 투자�; (ii) 중간 가� 변동성� 감수� � 있는 투자�; (iii) 현재 소득� 필요 없는 투자�; (iv) UBS 신용 위험� 감내� � 있는 투자�.

거래 경제�. UBS Securities LLC� 인수인으로서 노트� 2.50달러� 할인액을 수취하며, 이를 �3� 딜러에게 재분배할 � 있습니다. 발행 � UBS� 매수 호가� 내재� 판매 수수료만� 일시적으� 모델 가치보� 높을 � 있으�, � 수수료는 6개월 내에 상각됩니�.

중요 법률 � 세무 사항. SEC� 등록� 424B2 보충서는 2025� 2� 기본 설명�, 지� 보충� � 상품 보충서를 포함합니�. 미국 세법� � 노트� 조건부 지� 채무 상품으로 간주되어 OID(할인발행채권이자) 누적� 요구되므�, 투자자는 상세� CPDI 설명� 검토하� 자문가와 상담해야 합니�.

Présentation de la transaction. UBS AG commercialise des Notes Capped Market-Linked arrivant à échéance le 5 novembre 2026, titres de dette senior non garantis de la succursale de Londres. Ces notes sont liées à la moins bonne performance de trois indices boursiers majeurs américains : le Nasdaq-100 (NDX), le Russell 2000 (RTY) et le S&P 500 (SPX), avec une durée prévue de 15 mois (date de transaction le 1er août 2025 ; échéance le 5 novembre 2026).

Profil de rendement. � Montant nominal : 1 000 USD par note.
� Potentiel de gain : les investisseurs reçoivent la plus faible performance positive de l’indice le moins performant ou un Gain Maximum de 11,75 %, pour un paiement maximal de 1 117,50 USD.
� Risque à la baisse : si l’indice le moins performant est stable ou négatif, le remboursement est limité au principal, sans rendement additionnel.
Pas de coupons périodiques ; tous les flux de trésorerie sont versés à l’échéance.
� La performance est évaluée une seule fois, à la date finale du 2 novembre 2026.

Considérations sur les risques. Les notes sont exposées au risque de crédit d’UBS ; elles ne sont ni assurées par la FDIC ni garanties. La liquidité devrait être limitée : les titres ne seront pas cotés et la tenue de marché sur le marché secondaire par UBS Securities LLC est discrétionnaire. La valeur initiale estimée devrait se situer entre 96,23 % et 99,23 % de la valeur nominale, reflétant une décote à l’émission de 2,50 USD, les coûts de couverture et le taux interne de financement d’UBS. Les investisseurs sont exposés au risque de corrélation car le paiement dépend de la moins bonne performance ; les mouvements positifs des deux autres indices sont ignorés si un indice sous-performe.

Dates clés. Le règlement est prévu pour le 6 août 2025 (T+3). Comme les transactions secondaires aux États-Unis passent à T+1, les opérations anticipées peuvent nécessiter des arrangements spécifiques de règlement. La protection du capital s’applique uniquement si les notes sont détenues jusqu’� l’échéance.

Investisseurs ciblés. La section d’adéquation souligne les acheteurs qui : (i) recherchent une exposition action plafonnée avec remboursement intégral du capital ; (ii) peuvent tolérer la volatilité temporaire des prix ; (iii) n’ont pas besoin de revenus courants ; et (iv) acceptent le risque de crédit d’UBS.

Économie de l’opération. UBS Securities LLC agit en tant que souscripteur, percevant la décote de 2,50 USD par note, qu’elle peut rétrocéder à des distributeurs tiers. Après émission, l’offre d’achat d’UBS peut temporairement dépasser la valeur modèle jusqu’aux commissions de vente intégrées, qui s’amortissent à zéro en six mois.

Aspects juridiques et fiscaux importants. Le supplément 424B2 enregistré auprès de la SEC intègre le prospectus de base de février 2025, le supplément d’indices et le supplément produit. Aux fins fiscales américaines, les notes devraient être considérées comme des instruments de dette à paiement conditionnel, nécessitant une comptabilisation de l’OID ; les investisseurs doivent consulter la discussion détaillée sur les CPDI et prendre conseil auprès de leurs conseillers.

հԲپDzԲü. Die UBS AG bietet Capped Market-Linked Notes an, die am 5. November 2026 fällig werden und unbesicherte Senior-Schuldverschreibungen der Londoner Niederlassung sind. Die Notes sind an den schlechtesten der drei großen US-Aktienindizes Nasdaq-100 (NDX), Russell 2000 (RTY) und S&P 500 (SPX) gekoppelt und haben eine erwartete Laufzeit von 15 Monaten (Handelsdatum 1. August 2025; Fälligkeit 5. November 2026).

Renditeprofil. � Nennbetrag: 1.000 USD pro Note.
� Aufwärtspotenzial: Anleger erhalten die geringere positive Performance des schlechtesten Index oder eine feste Maximalrendite von 11,75 %, was eine maximale Auszahlung von 1.117,50 USD ergibt.
� Abwärtsrisiko: Liegt der schlechteste Index bei null oder im Minus, erfolgt die Rückzahlung auf den Nennwert begrenzt � ohne zusätzliche Rendite.
Keine periodischen Kupons; alle Zahlungen erfolgen bei Fälligkeit.
� Die Performance wird nur einmalig am 2. November 2026 bewertet.

Risikobetrachtungen. Die Notes unterliegen dem Kreditrisiko von UBS; sie sind weder durch die FDIC versichert noch besichert. Die Liquidität wird voraussichtlich begrenzt sein: Die Wertpapiere werden nicht börslich gehandelt, und das Market Making im Sekundärmarkt durch UBS Securities LLC erfolgt nach Ermessen. Der geschätzte Anfangswert liegt voraussichtlich zwischen 96,23 % und 99,23 % des Nennwerts, was einen Underwriting-Abschlag von 2,50 USD, Absicherungskosten und den internen Finanzierungssatz von UBS widerspiegelt. Anleger tragen ein Korrelationsrisiko, da die Auszahlung vom schlechtesten Performer abhängt; positive Bewegungen der anderen zwei Indizes werden ignoriert, wenn ein Index unterperformt.

Wichtige Termine. Die Abwicklung ist für den 6. August 2025 (T+3) vorgesehen. Da sekundäre US-Handelstransaktionen auf T+1 umgestellt werden, können frühere Trades spezielle Abwicklungsvereinbarungen erfordern. Der Kapitalschutz gilt nur bei Halt bis zur Fälligkeit.

Zielinvestoren. Der Eignungsabschnitt hebt Käufer hervor, die: (i) eine begrenzte Aktienexponierung mit vollständiger Kapitalrückzahlung suchen; (ii) kurzfristige Kursvolatilität tolerieren können; (iii) keine laufenden Erträge benötigen; und (iv) bereit sind, das Kreditrisiko von UBS zu tragen.

Wirtschaftlichkeit des Deals. UBS Securities LLC fungiert als Underwriter und verdient den Abschlag von 2,50 USD pro Note, der an Drittanbieter weitergegeben werden kann. Nach der Emission kann das Kaufangebot von UBS vorübergehend den Modellwert um die eingebetteten Verkaufsprovisionen übersteigen, die innerhalb von sechs Monaten amortisiert werden.

Wesentliche rechtliche und steuerliche Punkte. Der bei der SEC registrierte 424B2-Supplement enthält den Basisprospekt vom Februar 2025, den Index-Supplement und das Produktsupplement. Für US-Steuerzwecke werden die Notes voraussichtlich als Schuldinstrumente mit bedingter Zahlung behandelt, die eine OID-Akkumulation erfordern; Anleger sollten die detaillierte CPDI-Diskussion prüfen und Berater konsultieren.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Capped 11.75 % upside, principal protected at maturity, but worst-of-three index risk and UBS credit exposure render payoff asymmetric.

The structure offers modest equity participation�11.75 % maximum over roughly 15 months equates to ~9 % simple annualised—while guaranteeing 100 % principal at maturity. The cap looks adequate only if investors doubt >12 % appreciation of the worst index in the period. Historical 1-year volatilities (NDX�23 %, RTY�27 %, SPX�18 %) and correlations suggest a meaningful probability that at least one index finishes flat or negative, in which case the investor earns zero total return while an equity portfolio could post gains. For portfolio construction, the notes behave like a short OTC put on the worst index combined with a capped call, embedded within a UBS credit instrument. Risk-adjusted return therefore appears neutral for investors seeking short-term capital protection but unattractive for those comfortable holding diversified equities directly.

TL;DR: Principal is safe only if UBS remains solvent; limited liquidity, structural worst-of feature increases chance of zero return.

Credit risk dominates the downside tail: any UBS default triggers full loss potential, unlike insured deposits. The FINMA resolution framework empowers debt-to-equity conversions or write-offs ahead of senior deposit claims, explicitly highlighted in the supplement. Market risk is concentrated: the worst-performing index drives payout. Low cross-index correlation—particularly between tech-heavy NDX and small-cap RTY—elevates the probability of forfeiting upside. Secondary pricing is opaque; initial model value set at 96.23 %�99.23 % of par, meaning investors incur a ~0.8 %�3.8 % ‘day-one� mark-to-market drag. Liquidity risk is amplified by non-listing and discretionary market making.

Panoramica della transazione. UBS AG sta promuovendo Note Capped Market-Linked con scadenza il 5 novembre 2026, che sono titoli di debito senior non garantiti della filiale di Londra. Le note sono collegate al peggior rendimento tra tre principali indici azionari statunitensi: Nasdaq-100 (NDX), Russell 2000 (RTY) e S&P 500 (SPX), con una durata prevista di 15 mesi (data di negoziazione 1 agosto 2025; scadenza 5 novembre 2026).

Profilo di rendimento. � Importo nominale: 1.000 USD per nota.
� Potenziale guadagno: gli investitori ricevono il minore tra la performance positiva dell'indice peggiore e un Guadagno Massimo dell'11,75%, con un pagamento massimo di 1.117,50 USD.
� Rischio di perdita: se l'indice peggiore è stabile o negativo, il rimborso è limitato al capitale investito, senza ulteriori rendimenti.
Nessuna cedola periodica; tutti i flussi di cassa vengono corrisposti alla scadenza.
� La performance viene valutata una sola volta, alla data finale del 2 novembre 2026.

Considerazioni sui rischi. Le note sono soggette al rischio di credito di UBS; non sono assicurate dalla FDIC né garantite. La liquidità potrebbe essere limitata: i titoli non saranno quotati e la negoziazione sul mercato secondario da parte di UBS Securities LLC è discrezionale. Il valore iniziale stimato è previsto tra il 96,23% e il 99,23% del valore nominale, considerando uno sconto di sottoscrizione di 2,50 USD, costi di copertura e il tasso interno di finanziamento di UBS. Gli investitori affrontano un rischio di correlazione poiché il rendimento dipende dall'indice peggiore; eventuali movimenti positivi degli altri due indici sono ignorati se uno risulta sottoperformante.

Date chiave. Il regolamento è previsto per il 6 agosto 2025 (T+3). Poiché le negoziazioni secondarie negli USA passano a T+1, le operazioni anticipate potrebbero richiedere accordi di regolamento speciali. La protezione del capitale si applica solo se le note sono detenute fino alla scadenza.

Investitori target. La sezione di idoneità sottolinea gli acquirenti che: (i) cercano un'esposizione azionaria con limite massimo e rimborso completo del capitale; (ii) possono tollerare la volatilità dei prezzi nel breve termine; (iii) non necessitano di reddito corrente; e (iv) sono disposti a sostenere il rischio di credito di UBS.

Economia dell'operazione. UBS Securities LLC agisce come sottoscrittore, guadagnando uno sconto di 2,50 USD per nota, che può essere riconosciuto a rivenditori terzi. Dopo l'emissione, il prezzo di acquisto offerto da UBS può temporaneamente superare il valore teorico fino alle commissioni di vendita incorporate, che si ammortizzano a zero entro sei mesi.

Aspetti legali e fiscali rilevanti. Il supplemento 424B2 registrato presso la SEC incorpora il prospetto base di febbraio 2025, il supplemento indici e il supplemento prodotto. Ai fini fiscali statunitensi, le note sono considerate strumenti di debito con pagamento condizionato, richiedendo l'accumulo di OID; gli investitori dovrebbero esaminare la dettagliata discussione CPDI e consultare i propri consulenti.

Resumen de la transacción. UBS AG está promocionando Notas Vinculadas al Mercado con Límite Máximo con vencimiento el 5 de noviembre de 2026, que son valores de deuda senior no garantizados de la sucursal de Londres. Las notas están vinculadas al rendimiento más bajo de tres índices bursátiles estadounidenses principales: Nasdaq-100 (NDX), Russell 2000 (RTY) y S&P 500 (SPX), con un plazo esperado de 15 meses (fecha de operación 1 de agosto de 2025; vencimiento 5 de noviembre de 2026).

Perfil de rendimiento. � Importe nominal: 1,000 USD por nota.
� Potencial de ganancia: los inversores reciben el menor entre el rendimiento positivo del índice con peor desempeño y una Ganancia Máxima del 11.75%, con un pago máximo de 1,117.50 USD.
� Riesgo a la baja: si el índice peor está plano o negativo, el reembolso se limita al capital, sin rendimiento adicional.
No hay cupones periódicos; todos los flujos de efectivo se reciben al vencimiento.
� La valoración del rendimiento se realiza una sola vez, en la fecha final del 2 de noviembre de 2026.

Consideraciones de riesgo. Las notas están sujetas al riesgo crediticio de UBS; no están aseguradas por la FDIC ni garantizadas. Se espera que la liquidez sea limitada: los valores no estarán listados y la creación de mercado secundaria por UBS Securities LLC es discrecional. El valor inicial estimado se espera entre 96.23% y 99.23% del valor nominal, reflejando un descuento de suscripción de 2.50 USD, costos de cobertura y la tasa interna de financiamiento de UBS. Los inversores enfrentan riesgo de correlación porque el pago depende del peor índice; se ignoran los movimientos positivos de dos índices si uno tiene un desempeño inferior.

Fechas clave. La liquidación está programada para el 6 de agosto de 2025 (T+3). Debido a que las operaciones secundarias en EE.UU. cambian a T+1, las operaciones anticipadas pueden requerir arreglos especiales de liquidación. La protección del capital se aplica solo si las notas se mantienen hasta el vencimiento.

Inversores objetivo. La sección de idoneidad enfatiza a compradores que: (i) buscan exposición accionaria limitada con reembolso total del capital; (ii) pueden tolerar la volatilidad temporal del precio; (iii) no necesitan ingresos actuales; y (iv) están cómodos asumiendo el riesgo crediticio de UBS.

Economía de la operación. UBS Securities LLC actúa como suscriptor, ganando un descuento de 2.50 USD por nota, que puede ceder a distribuidores terceros. Tras la emisión, la oferta de UBS puede superar temporalmente el valor modelo hasta las concesiones de venta incorporadas, que se amortizan a cero en seis meses.

Aspectos legales y fiscales importantes. El suplemento 424B2 registrado en la SEC incorpora el prospecto base de febrero de 2025, el suplemento de índices y el suplemento del producto. Para fines fiscales en EE.UU., se espera que las notas se traten como instrumentos de deuda con pago contingente, requiriendo acumulación de OID; los inversores deben revisar la discusión detallada sobre CPDI y consultar asesores.

거래 개요. UBS AG� 2026� 11� 5� 만기� 상한선이 설정� 시장 연계 노트(Capped Market-Linked Notes)� 런던 지점의 무담� 선순� 채무 증권으로� 판매하고 있습니다. � 노트� 미국� 주요 3� 주가지� � 최저 성과 지�� 나스�-100(NDX), 러셀 2000(RTY), S&P 500(SPX)� 연동되며, 예상 만기 기간은 15개월입니�(거래� 2025� 8� 1�; 만기 2026� 11� 5�).

수익 구조. � 원금 금액: 노트� 미화 1,000달러.
� 상승 가능성: 투자자는 최저 성과 지수의 양의 수익률과 고정� 최대 수익� 11.75%� 낮은 수익� 받아 최대 지급액은 1,117.50달러입니�.
� 하락 위험: 최저 성과 지수가 변� 없거� 마이너스� 경우, 상환은 원금 한도� 제한되며 추가 수익은 없습니다.
정기 쿠폰 없음; 모든 현금 흐름은 만기� 지급됩니다.
� 성과 평가� 2026� 11� 2� 최종 평가일에 � � � 이루어집니다.

위험 고려 사항. � 노트� UBS� 신용 위험� 노출되어 있으�, FDIC 보험 적용 대상이 아니� 담보� 없습니다. 유동성은 제한적일 것으� 예상되며, 증권은 상장되지 않고 UBS Securities LLC� 2� 시장 조성은 재량� 따릅니다. 초기 예상 가�� 액면가� 96.23%~99.23% 사이�, 2.50달러� 인수 수수�, 헤지 비용 � UBS 내부 자금 조달 비용� 반영합니�. 투자자는 수익� 최저 성과 지수에 따라 결정되므� 상관관� 위험� 노출되며, � 지수가 저조하� 다른 � 지수의 긍정� 움직임은 무시됩니�.

주요 일정. 결제� 2025� 8� 6�(T+3)� 예정되어 있습니다. 미국 2� 거래가 T+1� 변경됨� 따라 조기 거래� 특별 결제 조정� 필요� � 있습니다. 원금 보호� 노트� 만기까지 보유� 경우에만 적용됩니�.

대� 투자�. 적합� 섹션은 다음� 같은 투자자를 강조합니�: (i) 최대 수익 한도가 있는 주식 노출� 원금 전액 상환� 원하� 투자�; (ii) 중간 가� 변동성� 감수� � 있는 투자�; (iii) 현재 소득� 필요 없는 투자�; (iv) UBS 신용 위험� 감내� � 있는 투자�.

거래 경제�. UBS Securities LLC� 인수인으로서 노트� 2.50달러� 할인액을 수취하며, 이를 �3� 딜러에게 재분배할 � 있습니다. 발행 � UBS� 매수 호가� 내재� 판매 수수료만� 일시적으� 모델 가치보� 높을 � 있으�, � 수수료는 6개월 내에 상각됩니�.

중요 법률 � 세무 사항. SEC� 등록� 424B2 보충서는 2025� 2� 기본 설명�, 지� 보충� � 상품 보충서를 포함합니�. 미국 세법� � 노트� 조건부 지� 채무 상품으로 간주되어 OID(할인발행채권이자) 누적� 요구되므�, 투자자는 상세� CPDI 설명� 검토하� 자문가와 상담해야 합니�.

Présentation de la transaction. UBS AG commercialise des Notes Capped Market-Linked arrivant à échéance le 5 novembre 2026, titres de dette senior non garantis de la succursale de Londres. Ces notes sont liées à la moins bonne performance de trois indices boursiers majeurs américains : le Nasdaq-100 (NDX), le Russell 2000 (RTY) et le S&P 500 (SPX), avec une durée prévue de 15 mois (date de transaction le 1er août 2025 ; échéance le 5 novembre 2026).

Profil de rendement. � Montant nominal : 1 000 USD par note.
� Potentiel de gain : les investisseurs reçoivent la plus faible performance positive de l’indice le moins performant ou un Gain Maximum de 11,75 %, pour un paiement maximal de 1 117,50 USD.
� Risque à la baisse : si l’indice le moins performant est stable ou négatif, le remboursement est limité au principal, sans rendement additionnel.
Pas de coupons périodiques ; tous les flux de trésorerie sont versés à l’échéance.
� La performance est évaluée une seule fois, à la date finale du 2 novembre 2026.

Considérations sur les risques. Les notes sont exposées au risque de crédit d’UBS ; elles ne sont ni assurées par la FDIC ni garanties. La liquidité devrait être limitée : les titres ne seront pas cotés et la tenue de marché sur le marché secondaire par UBS Securities LLC est discrétionnaire. La valeur initiale estimée devrait se situer entre 96,23 % et 99,23 % de la valeur nominale, reflétant une décote à l’émission de 2,50 USD, les coûts de couverture et le taux interne de financement d’UBS. Les investisseurs sont exposés au risque de corrélation car le paiement dépend de la moins bonne performance ; les mouvements positifs des deux autres indices sont ignorés si un indice sous-performe.

Dates clés. Le règlement est prévu pour le 6 août 2025 (T+3). Comme les transactions secondaires aux États-Unis passent à T+1, les opérations anticipées peuvent nécessiter des arrangements spécifiques de règlement. La protection du capital s’applique uniquement si les notes sont détenues jusqu’� l’échéance.

Investisseurs ciblés. La section d’adéquation souligne les acheteurs qui : (i) recherchent une exposition action plafonnée avec remboursement intégral du capital ; (ii) peuvent tolérer la volatilité temporaire des prix ; (iii) n’ont pas besoin de revenus courants ; et (iv) acceptent le risque de crédit d’UBS.

Économie de l’opération. UBS Securities LLC agit en tant que souscripteur, percevant la décote de 2,50 USD par note, qu’elle peut rétrocéder à des distributeurs tiers. Après émission, l’offre d’achat d’UBS peut temporairement dépasser la valeur modèle jusqu’aux commissions de vente intégrées, qui s’amortissent à zéro en six mois.

Aspects juridiques et fiscaux importants. Le supplément 424B2 enregistré auprès de la SEC intègre le prospectus de base de février 2025, le supplément d’indices et le supplément produit. Aux fins fiscales américaines, les notes devraient être considérées comme des instruments de dette à paiement conditionnel, nécessitant une comptabilisation de l’OID ; les investisseurs doivent consulter la discussion détaillée sur les CPDI et prendre conseil auprès de leurs conseillers.

հԲپDzԲü. Die UBS AG bietet Capped Market-Linked Notes an, die am 5. November 2026 fällig werden und unbesicherte Senior-Schuldverschreibungen der Londoner Niederlassung sind. Die Notes sind an den schlechtesten der drei großen US-Aktienindizes Nasdaq-100 (NDX), Russell 2000 (RTY) und S&P 500 (SPX) gekoppelt und haben eine erwartete Laufzeit von 15 Monaten (Handelsdatum 1. August 2025; Fälligkeit 5. November 2026).

Renditeprofil. � Nennbetrag: 1.000 USD pro Note.
� Aufwärtspotenzial: Anleger erhalten die geringere positive Performance des schlechtesten Index oder eine feste Maximalrendite von 11,75 %, was eine maximale Auszahlung von 1.117,50 USD ergibt.
� Abwärtsrisiko: Liegt der schlechteste Index bei null oder im Minus, erfolgt die Rückzahlung auf den Nennwert begrenzt � ohne zusätzliche Rendite.
Keine periodischen Kupons; alle Zahlungen erfolgen bei Fälligkeit.
� Die Performance wird nur einmalig am 2. November 2026 bewertet.

Risikobetrachtungen. Die Notes unterliegen dem Kreditrisiko von UBS; sie sind weder durch die FDIC versichert noch besichert. Die Liquidität wird voraussichtlich begrenzt sein: Die Wertpapiere werden nicht börslich gehandelt, und das Market Making im Sekundärmarkt durch UBS Securities LLC erfolgt nach Ermessen. Der geschätzte Anfangswert liegt voraussichtlich zwischen 96,23 % und 99,23 % des Nennwerts, was einen Underwriting-Abschlag von 2,50 USD, Absicherungskosten und den internen Finanzierungssatz von UBS widerspiegelt. Anleger tragen ein Korrelationsrisiko, da die Auszahlung vom schlechtesten Performer abhängt; positive Bewegungen der anderen zwei Indizes werden ignoriert, wenn ein Index unterperformt.

Wichtige Termine. Die Abwicklung ist für den 6. August 2025 (T+3) vorgesehen. Da sekundäre US-Handelstransaktionen auf T+1 umgestellt werden, können frühere Trades spezielle Abwicklungsvereinbarungen erfordern. Der Kapitalschutz gilt nur bei Halt bis zur Fälligkeit.

Zielinvestoren. Der Eignungsabschnitt hebt Käufer hervor, die: (i) eine begrenzte Aktienexponierung mit vollständiger Kapitalrückzahlung suchen; (ii) kurzfristige Kursvolatilität tolerieren können; (iii) keine laufenden Erträge benötigen; und (iv) bereit sind, das Kreditrisiko von UBS zu tragen.

Wirtschaftlichkeit des Deals. UBS Securities LLC fungiert als Underwriter und verdient den Abschlag von 2,50 USD pro Note, der an Drittanbieter weitergegeben werden kann. Nach der Emission kann das Kaufangebot von UBS vorübergehend den Modellwert um die eingebetteten Verkaufsprovisionen übersteigen, die innerhalb von sechs Monaten amortisiert werden.

Wesentliche rechtliche und steuerliche Punkte. Der bei der SEC registrierte 424B2-Supplement enthält den Basisprospekt vom Februar 2025, den Index-Supplement und das Produktsupplement. Für US-Steuerzwecke werden die Notes voraussichtlich als Schuldinstrumente mit bedingter Zahlung behandelt, die eine OID-Akkumulation erfordern; Anleger sollten die detaillierte CPDI-Diskussion prüfen und Berater konsultieren.

Preliminary Pricing Supplement No. 9,233

Registration Statement Nos. 333-275587; 333-275587-01

Dated July 8, 2025

Filed pursuant to Rule 424(b)(2)

Morgan Stanley Finance LLC

Structured Investments

Contingent Income Memory Auto-Callable Securities due July 27, 2028

Based on the Worst Performing of the Common Stock of Bank of America Corporation, the Common Stock of The Goldman Sachs Group, Inc. and the Common Stock of JPMorgan Chase & Co.

Fully and Unconditionally Guaranteed by Morgan Stanley

Principal at Risk Securities

The securities are unsecured obligations of Morgan Stanley Finance LLC (“MSFL”) and are fully and unconditionally guaranteed by Morgan Stanley. The securities have the terms described in the accompanying product supplement and prospectus, as supplemented or modified by this document. The securities do not guarantee the repayment of principal and do not provide for the regular payment of interest.

Contingent coupon. The securities will pay a contingent coupon (as well as any previously unpaid contingent coupons) but only if the closing level of each underlier is greater than or equal to its coupon barrier level on the related observation date. However, if the closing level of any underlier is less than its coupon barrier level on any observation date, we will pay no interest with respect to the related interest period.

Automatic early redemption. The securities will be automatically redeemed if the closing level of each underlier is greater than or equal to its call threshold level on any redemption determination date for an early redemption payment equal to the stated principal amount plus the contingent coupon with respect to the related interest period and any previously unpaid contingent coupons. No further payments will be made on the securities once they have been automatically redeemed.

Payment at maturity. If the securities have not been automatically redeemed prior to maturity and the final level of each underlier is greater than or equal to its downside threshold level, investors will receive (in addition to the contingent coupon with respect to the final observation date and any previously unpaid contingent coupons, if payable) the stated principal amount at maturity. If, however, the final level of any underlier is less than its downside threshold level, investors will lose 1% for every 1% decline in the level of the worst performing underlier over the term of the securities. Under these circumstances, the payment at maturity will be significantly less than the stated principal amount and could be zero.

The value of the securities is based on the worst performing underlier. The fact that the securities are linked to more than one underlier does not provide any asset diversification benefits and instead means that a decline in the level of any underlier beyond its coupon barrier level and/or downside threshold level will adversely affect your return on the securities, even if the other underliers have appreciated or have not declined as much.

The securities are for investors who seek an opportunity to earn interest at a potentially above-market rate in exchange for the risk of losing a significant portion or all of their principal and the risk of receiving no coupons over the entire term of the securities. You will not participate in any appreciation of any underlier. Investors in the securities must be willing to accept the risk of losing their entire initial investment based on the performance of any underlier. The securities are notes issued as part of MSFL’s Series A Global Medium-Term Notes program.

All payments are subject to our credit risk. If we default on our obligations, you could lose some or all of your investment. These securities are not secured obligations and you will not have any security interest in, or otherwise have any access to, any underlying reference asset or assets.

TERMS

Issuer:

Morgan Stanley Finance LLC

Guarantor:

Morgan Stanley

Stated principal amount:

$1,000 per security

Issue price:

$1,000 per security (see “Commissions and issue price” below)

Aggregate principal amount:

$

Underliers:

Bank of America Corporation common stock (the “BAC Stock”), The Goldman Sachs Group, Inc. common stock (the “GS Stock”) and JPMorgan Chase & Co. common stock (the “JPM Stock”). We refer to each of the BAC Stock, the GS Stock and the JPM Stock as an underlying stock.

Strike date:

July 22, 2025

Pricing date:

July 22, 2025

Original issue date:

July 25, 2025

Final observation date:

July 24, 2028, subject to postponement for non-trading days and certain market disruption events

Maturity date:

July 27, 2028

Terms continued on the following page

Agent:

Morgan Stanley & Co. LLC (“MS & Co.”), an affiliate of MSFL and a wholly owned subsidiary of Morgan Stanley. See “Supplemental information regarding plan of distribution; conflicts of interest.”

Estimated value on the pricing date:

Approximately $958.60 per security, or within $45.00 of that estimate. See “Estimated Value of the Securities” on page 4.

Commissions and issue price:

Price to public

Agent’s commissions and fees(1)

Proceeds to us(2)

Per security

$1,000

$

$

Total

$

$

$

(1)Selected dealers and their financial advisors will collectively receive from the agent, MS & Co., a fixed sales commission of $ for each security they sell. See “Supplemental information regarding plan of distribution; conflicts of interest.” For additional information, see “Plan of Distribution (Conflicts of Interest)” in the accompanying product supplement.

(2)See “Use of Proceeds and Hedging” in the accompanying product supplement.

The securities involve risks not associated with an investment in ordinary debt securities. See “Risk Factors” beginning on page 9.

The Securities and Exchange Commission and state securities regulators have not approved or disapproved these securities, or determined if this document or the accompanying product supplement and prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

The securities are not deposits or savings accounts and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency or instrumentality, nor are they obligations of, or guaranteed by, a bank.

You should read this document together with the related product supplement and prospectus, each of which can be accessed via the hyperlinks below. Please also see “Additional Terms of the Securities” and “Additional Information About the Securities” at the end of this document.

References to “we,” “us” and “our” refer to Morgan Stanley or MSFL, or Morgan Stanley and MSFL collectively, as the context requires.

Product Supplement for Principal at Risk Securities dated February 7, 2025 Prospectus dated April 12, 2024

 

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

Terms continued from the previous page

Automatic early redemption:

The securities are not subject to automatic early redemption until the first redemption determination date. If, on any redemption determination date, the closing level of each underlier is greater than or equal to its call threshold level, the securities will be automatically redeemed for the early redemption payment on the related early redemption date. No further payments will be made on the securities once they have been automatically redeemed.

The securities will not be redeemed on any early redemption date if the closing level of any underlier is less than its call threshold level on the related redemption determination date.

First redemption determination date:

January 22, 2026. Under no circumstances will the securities be redeemed prior to the first redemption determination date.

Redemption determination dates:

January 22, 2026, February 23, 2026, March 23, 2026, April 22, 2026, May 22, 2026, June 22, 2026, July 22, 2026, August 24, 2026, September 22, 2026, October 22, 2026, November 23, 2026, December 22, 2026, January 22, 2027, February 22, 2027, March 22, 2027, April 22, 2027, May 24, 2027, June 22, 2027, July 22, 2027, August 23, 2027, September 22, 2027, October 22, 2027, November 22, 2027, December 22, 2027, January 24, 2028, February 22, 2028, March 22, 2028, April 24, 2028, May 22, 2028 and June 22, 2028, subject to postponement for non-trading days and certain market disruption events.

Call threshold level:

With respect to the BAC Stock, $ , which is 95% of its initial level

With respect to the GS Stock, $ , which is 95% of its initial level

With respect to the JPM Stock, $ , which is 95% of its initial level

Early redemption payment:

The stated principal amount plus the contingent coupon with respect to the related interest period and any previously unpaid contingent coupons

Early redemption dates:

January 27, 2026, February 26, 2026, March 26, 2026, April 27, 2026, May 28, 2026, June 25, 2026, July 27, 2026, August 27, 2026, September 25, 2026, October 27, 2026, November 27, 2026, December 28, 2026, January 27, 2027, February 25, 2027, March 25, 2027, April 27, 2027, May 27, 2027, June 25, 2027, July 27, 2027, August 26, 2027, September 27, 2027, October 27, 2027, November 26, 2027, December 27, 2027, January 27, 2028, February 25, 2028, March 27, 2028, April 27, 2028, May 25, 2028 and June 27, 2028

Contingent coupon:

A contingent coupon at an annual rate of 9.85% will be paid on the securities on each coupon payment date but only if the closing level of each underlier is greater than or equal to its coupon barrier level on the related observation date.

If the contingent coupon is not paid on any coupon payment date (because the closing level of any underlier is less than its coupon barrier level on the related observation date), such unpaid contingent coupon will be paid on a later coupon payment date but only if the closing level of each underlier is greater than or equal to its coupon barrier level on the related observation date. Any such unpaid contingent coupon will be paid on the first subsequent coupon payment date for which the closing level of each underlier is greater than or equal to its coupon barrier level on the related observation date; provided, however, in the case of any such payment of a previously unpaid contingent coupon, no additional interest shall accrue or be payable in respect of such unpaid contingent coupon from and after the end of the original interest period for such unpaid contingent coupon.

You will not receive payment for any unpaid contingent coupons if the closing level of any underlier is less than its coupon barrier level on each subsequent observation date.

Coupon payment dates:

As set forth under “Observation Dates and Coupon Payment Dates” below. If any coupon payment date is not a business day, the coupon payment with respect to such date, if any, will be made on the next succeeding business day and no adjustment will be made to any coupon payment made on that succeeding business day. The coupon payment, if any, with respect to the final observation date shall be made on the maturity date.

Coupon barrier level:

With respect to the BAC Stock, $ , which is 65% of its initial level

With respect to the GS Stock, $ , which is 65% of its initial level

With respect to the JPM Stock, $ , which is 65% of its initial level

Observation dates:

As set forth under “Observation Dates and Coupon Payment Dates” below, subject to postponement for non-trading days and certain market disruption events

Payment at maturity per security:

If the securities have not been automatically redeemed prior to maturity, investors will receive (in addition to the contingent coupon with respect to the final observation date and any previously unpaid contingent coupons, if payable) a payment at maturity determined as follows:

If the final level of each underlier is greater than or equal to its downside threshold level:

stated principal amount

If the final level of any underlier is less than its downside threshold level:

stated principal amount × performance factor of the worst performing underlier

Under these circumstances, the payment at maturity will be significantly less than the stated principal amount and could be zero.

Final level:

With respect to each underlier, the closing level on the final observation date

Downside threshold level:

With respect to the BAC Stock, $ , which is 65% of its initial level

With respect to the GS Stock, $ , which is 65% of its initial level

With respect to the JPM Stock, $ , which is 65% of its initial level

Performance factor:

With respect to each underlier, final level / initial level

Worst performing underlier:

The underlier with the lowest percentage return from its initial level to its final level

Initial level:

With respect to the BAC Stock, $ , which is its closing level on the strike date

With respect to the GS Stock, $ , which is its closing level on the strike date

With respect to the JPM Stock, $ , which is its closing level on the strike date

 Page 2

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

Closing level:

“Closing level” and “adjustment factor” have the meanings set forth under “General Terms of the Securities—Some Definitions” in the accompanying product supplement.

CUSIP:

61778NHY0

ISIN:

US61778NHY04

Listing:

The securities will not be listed on any securities exchange.

Observation Dates and Coupon Payment Dates

Observation Dates

Coupon Payment Dates

August 22, 2025

August 27, 2025

September 22, 2025

September 25, 2025

October 22, 2025

October 27, 2025

November 24, 2025

November 28, 2025

December 22, 2025

December 26, 2025

January 22, 2026

January 27, 2026

February 23, 2026

February 26, 2026

March 23, 2026

March 26, 2026

April 22, 2026

April 27, 2026

May 22, 2026

May 28, 2026

June 22, 2026

June 25, 2026

July 22, 2026

July 27, 2026

August 24, 2026

August 27, 2026

September 22, 2026

September 25, 2026

October 22, 2026

October 27, 2026

November 23, 2026

November 27, 2026

December 22, 2026

December 28, 2026

January 22, 2027

January 27, 2027

February 22, 2027

February 25, 2027

March 22, 2027

March 25, 2027

April 22, 2027

April 27, 2027

May 24, 2027

May 27, 2027

June 22, 2027

June 25, 2027

July 22, 2027

July 27, 2027

August 23, 2027

August 26, 2027

September 22, 2027

September 27, 2027

October 22, 2027

October 27, 2027

November 22, 2027

November 26, 2027

December 22, 2027

December 27, 2027

January 24, 2028

January 27, 2028

February 22, 2028

February 25, 2028

March 22, 2028

March 27, 2028

April 24, 2028

April 27, 2028

May 22, 2028

May 25, 2028

June 22, 2028

June 27, 2028

July 24, 2028 (final observation date)

July 27, 2028 (maturity date)

 

 Page 3

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

Estimated Value of the Securities

The original issue price of each security is $1,000. This price includes costs associated with issuing, selling, structuring and hedging the securities, which are borne by you, and, consequently, the estimated value of the securities on the pricing date will be less than $1,000. Our estimate of the value of the securities as determined on the pricing date will be within the range specified on the cover hereof and will be set forth on the cover of the final pricing supplement.

What goes into the estimated value on the pricing date?

In valuing the securities on the pricing date, we take into account that the securities comprise both a debt component and a performance-based component linked to the underliers. The estimated value of the securities is determined using our own pricing and valuation models, market inputs and assumptions relating to the underliers, instruments based on the underliers, volatility and other factors including current and expected interest rates, as well as an interest rate related to our secondary market credit spread, which is the implied interest rate at which our conventional fixed rate debt trades in the secondary market.

What determines the economic terms of the securities?

In determining the economic terms of the securities, we use an internal funding rate, which is likely to be lower than our secondary market credit spreads and therefore advantageous to us. If the issuing, selling, structuring and hedging costs borne by you were lower or if the internal funding rate were higher, one or more of the economic terms of the securities would be more favorable to you.

What is the relationship between the estimated value on the pricing date and the secondary market price of the securities?

The price at which MS & Co. purchases the securities in the secondary market, absent changes in market conditions, including those related to the underliers, may vary from, and be lower than, the estimated value on the pricing date, because the secondary market price takes into account our secondary market credit spread as well as the bid-offer spread that MS & Co. would charge in a secondary market transaction of this type and other factors. However, because the costs associated with issuing, selling, structuring and hedging the securities are not fully deducted upon issuance, to the extent that MS & Co. may buy or sell the securities in the secondary market during the amortization period specified herein, absent changes in market conditions, including those related to the underliers, and to our secondary market credit spreads, it would do so based on values higher than the estimated value. We expect that those higher values will also be reflected in your brokerage account statements.

MS & Co. may, but is not obligated to, make a market in the securities, and, if it once chooses to make a market, may cease doing so at any time.

 Page 4

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

Hypothetical Examples

The following hypothetical examples illustrate how to determine whether the securities will be automatically redeemed with respect to a redemption determination date, whether a contingent coupon is payable with respect to an observation date and how to calculate the payment at maturity if the securities have not been automatically redeemed prior to maturity. The following examples are for illustrative purposes only. Whether the securities are automatically redeemed prior to maturity will be determined by reference to the closing level of each underlier on each redemption determination date. Whether you receive a contingent coupon will be determined by reference to the closing level of each underlier on each observation date. The payment at maturity will be determined by reference to the closing level of each underlier on the final observation date. The actual initial level, call threshold level, coupon barrier level and downside threshold level for each underlier will be determined on the strike date. All payments on the securities are subject to our credit risk. The numbers in the hypothetical examples below may have been rounded for ease of analysis. The below examples are based on the following terms:

Stated principal amount:

$1,000 per security

Hypothetical initial level:

With respect to the BAC Stock, $100.00*

With respect to the GS Stock, $100.00*

With respect to the JPM Stock, $100.00*

Hypothetical call threshold level:

With respect to the BAC Stock, $95.00, which is 95% of its hypothetical initial level

With respect to the GS Stock, $95.00, which is 95% of its hypothetical initial level

With respect to the JPM Stock, $95.00, which is 95% of its hypothetical initial level

Hypothetical coupon barrier level:

With respect to the BAC Stock, $65.00, which is 65% of its hypothetical initial level

With respect to the GS Stock, $65.00, which is 65% of its hypothetical initial level

With respect to the JPM Stock, $65.00, which is 65% of its hypothetical initial level

Hypothetical downside threshold level:

With respect to the BAC Stock, $65.00, which is 65% of its hypothetical initial level

With respect to the GS Stock, $65.00, which is 65% of its hypothetical initial level

With respect to the JPM Stock, $65.00, which is 65% of its hypothetical initial level

Contingent coupon:

9.85% per annum (corresponding to approximately $8.208 per interest period per security). The actual contingent coupon will be an amount determined by the calculation agent based on the number of days in the applicable payment period, calculated on a 30/360 day-count basis. The hypothetical contingent coupon of $8.208 is used in these examples for ease of analysis.

If the contingent coupon is not paid on any coupon payment date (because the closing level of any underlier is less than its coupon barrier level on the related observation date), such unpaid contingent coupon will be paid on a later coupon payment date but only if the closing level of each underlier is greater than or equal to its coupon barrier level on the related observation date. Any such unpaid contingent coupon will be paid on the first subsequent coupon payment date for which the closing level of each underlier is greater than or equal to its coupon barrier level on the related observation date.

*The hypothetical initial level of $100.00 for each underlier has been chosen for illustrative purposes only and does not represent the actual initial level of any underlier. Please see “Historical Information” below for historical data regarding the actual closing levels of the underliers.

 Page 5

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

How to determine whether the securities will be automatically redeemed with respect to a redemption determination date:

 

Closing Level

Early Redemption Payment

BAC Stock

GS Stock

JPM Stock

Hypothetical Redemption Determination Date #1

$105.00 (greater than or equal to its call threshold level)

$45.00 (less than its call threshold level)

$110.00 (greater than or equal to its call threshold level)

N/A

Hypothetical Redemption Determination Date #2

$110.00 (greater than or equal to its call threshold level)

$125.00 (greater than or equal to its call threshold level)

$115.00 (greater than or equal to its call threshold level)

The stated principal amount + the contingent coupon with respect to the related interest period and any previously unpaid contingent coupons

For more information, please see “How to determine whether a contingent coupon is payable with respect to an observation date (if the securities have not been previously automatically redeemed)” below.

On hypothetical redemption determination date #1, because the closing level of at least one underlier is less than its call threshold level, the securities are not automatically redeemed on the related early redemption date.

On hypothetical redemption determination date #2, because the closing level of each underlier is greater than or equal to its call threshold level, the securities are automatically redeemed on the related early redemption date for an early redemption payment equal to the stated principal amount plus the contingent coupon with respect to the related interest period and any previously unpaid contingent coupons. No further payments are made on the securities once they have been automatically redeemed.

If the closing level of any underlier is less than its call threshold level on each redemption determination date, the securities will not be automatically redeemed prior to maturity.

 Page 6

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

How to determine whether a contingent coupon is payable with respect to an observation date (if the securities have not been previously automatically redeemed):

 

Closing Level

Payment per Security

BAC Stock

GS Stock

JPM Stock

Hypothetical Observation Date #1

$80.00 (greater than or equal to its coupon barrier level)

$85.00 (greater than or equal to its coupon barrier level)

$90.00 (greater than or equal to its coupon barrier level)

$8.208

Hypothetical Observation Date #2

$55.00 (less than its coupon barrier level)

$45.00 (less than its coupon barrier level)

$110.00 (greater than or equal to its coupon barrier level)

$0

Hypothetical Observation Date #3

$95.00 (greater than or equal to its coupon barrier level)

$30.00 (less than its coupon barrier level)

$85.00 (greater than or equal to its coupon barrier level)

$0

Hypothetical Observation Date #4

$95.00 (greater than or equal to its coupon barrier level)

$90.00 (greater than or equal to its coupon barrier level)

$85.00 (greater than or equal to its coupon barrier level)

$8.208 + $8.208 + $8.208 = $24.624

Hypothetical Observation Date #5

$40.00 (less than its coupon barrier level)

$20.00 (less than its coupon barrier level)

$30.00 (less than its coupon barrier level)

$0

On hypothetical observation date #1, because the closing level of each underlier is greater than or equal to its coupon barrier level, the contingent coupon is paid on the related coupon payment date.

On hypothetical observation dates #2 and #3, because the closing level of at least one underlier is less than its coupon barrier level, no contingent coupon is paid on the related coupon payment date.

On hypothetical observation date #4, because the closing level of each underlier is greater than or equal to its coupon barrier level, investors receive the contingent coupon with respect to hypothetical observation date #4 as well as the previously unpaid contingent coupons with respect to hypothetical observation dates #2 and #3.

On hypothetical observation date #5, because the closing level of at least one underlier is less than its coupon barrier level, no contingent coupon is paid on the related coupon payment date.

If the closing level of any underlier is less than its coupon barrier level on each observation date, you will not receive any contingent coupons for the entire term of the securities.

 Page 7

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

How to calculate the payment at maturity (if the securities have not been automatically redeemed):

The hypothetical examples below illustrate how to calculate the payment at maturity if the securities have not been automatically redeemed prior to maturity.

 

Final Level

Payment at Maturity per Security

BAC Stock

GS Stock

JPM Stock

Example #1

$110.00 (greater than or equal to its downside threshold level)

$125.00 (greater than or equal to its downside threshold level)

$115.00 (greater than or equal to its downside threshold level)

The stated principal amount + the contingent coupon with respect to the final observation date and any previously unpaid contingent coupons

For more information, please see “How to determine whether a contingent coupon is payable with respect to an observation date (if the securities have not been previously automatically redeemed)” above.

Example #2

$85.00 (greater than or equal to its downside threshold level)

$45.00 (less than its downside threshold level)

$110.00 (greater than or equal to its downside threshold level)

$1,000 × performance factor of the worst performing underlier = $1,000 × ($45.00 / $100.00) = $450.00

Example #3

$50.00 (less than its downside threshold level)

$30.00 (less than its downside threshold level)

$20.00 (less than its downside threshold level)

$1,000 × ($20.00 / $100.00) = $200.00

In example #1, the final level of each underlier is greater than or equal to its downside threshold level. Therefore, investors receive at maturity the stated principal amount. Because the final level of each underlier is also greater than or equal to its coupon barrier level, investors receive the contingent coupon with respect to the final observation date and any previously unpaid contingent coupons. Investors do not participate in any appreciation of any underlier.

In examples #2 and #3, the final level of at least one underlier is less than its downside threshold level. Therefore, investors receive at maturity a payment that reflects a loss of 1% of principal for each 1% decline in the level of the worst performing underlier. Moreover, because the final level of at least one underlier is also less than its coupon barrier level, investors do not receive a contingent coupon with respect to the final observation date or any previously unpaid contingent coupons.

If the securities have not been automatically redeemed prior to maturity and the final level of any underlier is less than its downside threshold level, you will be exposed to the negative performance of the worst performing underlier at maturity, and your payment at maturity will be significantly less than the stated principal amount of the securities and could be zero.

 Page 8

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

Risk Factors

This section describes the material risks relating to the securities. For further discussion of these and other risks, you should read the section entitled “Risk Factors” in the accompanying product supplement and prospectus. We also urge you to consult with your investment, legal, tax, accounting and other advisers in connection with your investment in the securities.

Risks Relating to an Investment in the Securities

The securities do not guarantee the return of any principal. The terms of the securities differ from those of ordinary debt securities in that they do not guarantee the repayment of any principal. If the securities have not been automatically redeemed prior to maturity and the final level of any underlier is less than its downside threshold level, the payout at maturity will be an amount in cash that is significantly less than the stated principal amount of each security, and you will lose an amount proportionate to the full decline in the level of the worst performing underlier over the term of the securities. There is no minimum payment at maturity on the securities, and, accordingly, you could lose your entire initial investment in the securities.

The securities do not provide for the regular payment of interest. The terms of the securities differ from those of ordinary debt securities in that they do not provide for the regular payment of interest. Instead, the securities will pay a contingent coupon on a coupon payment date but only if the closing level of each underlier is greater than or equal to its coupon barrier level on the related observation date. However, if the closing level of any underlier is less than its coupon barrier level on any observation date, we will pay no coupon with respect to the applicable interest period. Any such unpaid contingent coupon will be paid on a subsequent coupon payment date but only if the closing level of each underlier is greater than or equal to its coupon barrier level on the related observation date. You will not receive payment for any such unpaid contingent coupon if the closing level of any underlier is less than its coupon barrier level on each subsequent observation date. It is possible that the closing level of an underlier will remain below its coupon barrier level for extended periods of time or even throughout the entire term of the securities so that you will receive few or no contingent coupons. If you do not earn sufficient contingent coupons over the term of the securities, the overall return on the securities may be less than the amount that would be paid on a conventional debt security of ours of comparable maturity.

Payment of the contingent coupon is based on the closing levels of the underliers on only the related observation date at the end of the related interest period. Whether the contingent coupon will be paid on any coupon payment date will be determined at the end of the related interest period based on the closing level of each underlier on the related observation date. As a result, you will not know whether you will receive the contingent coupon on a coupon payment date until near the end of the relevant interest period. Moreover, because the contingent coupon is based solely on the closing levels of the underliers on the observation dates, if the closing level of any underlier on any observation date is less than its coupon barrier level, you will not receive a contingent coupon with respect to the related interest period (or any previously unpaid contingent coupons), even if the closing level of such underlier was greater than or equal to its coupon barrier level on other days during that interest period and even if the closing levels of the other underliers are greater than or equal to their coupon barrier levels on such observation date.

Investors will not participate in any appreciation in the value of any underlier. Investors will not participate in any appreciation in the value of any underlier from the strike date to the final observation date, and the return on the securities will be limited to the contingent coupons that are paid with respect to the observation dates on which the closing level of each underlier is greater than or equal to its coupon barrier level. It is possible that the closing level of an underlier will remain below its coupon barrier level for extended periods of time or even throughout the entire term of the securities so that you will receive few or no contingent coupons.

The securities are subject to early redemption risk. The term of your investment in the securities may be shortened due to the automatic early redemption feature of the securities. If the securities are automatically redeemed prior to maturity, you will receive no further payments on the securities, may be forced to invest in a lower interest rate environment and may not be able to reinvest at comparable terms or returns. However, under no circumstances will the securities be redeemed prior to the first redemption determination date.

The market price of the securities may be influenced by many unpredictable factors. Several factors, many of which are beyond our control, will influence the value of the securities in the secondary market and the price at which MS & Co. may be willing to purchase or sell the securities in the secondary market. We expect that generally the value of each underlier at any time will affect the value of the securities more than any other single factor. Other factors that may influence the value of the securities include:

othe volatility (frequency and magnitude of changes in value) of the underliers;

ointerest and yield rates in the market;

odividend rates on the underliers;

othe level of correlation between the underliers;

ogeopolitical conditions and economic, financial, political, regulatory or judicial events that affect the underliers or equity markets generally;

 Page 9

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

othe availability of comparable instruments;

othe occurrence of certain events affecting the underliers that may or may not require an adjustment to an adjustment factor;

othe time remaining until the securities mature; and

oany actual or anticipated changes in our credit ratings or credit spreads.

Some or all of these factors will influence the price that you will receive if you sell your securities prior to maturity. Generally, the longer the time remaining to maturity, the more the market price of the securities will be affected by the other factors described above. For example, you may have to sell your securities at a substantial discount from the stated principal amount if, at the time of sale, the closing level of any underlier is at, below or not sufficiently above its downside threshold level and/or coupon barrier level, or if market interest rates rise.

You can review the historical closing levels of the underliers in the section of this document called “Historical Information.” You cannot predict the future performance of an underlier based on its historical performance. The values of the underliers may be, and have recently been, volatile, and we can give you no assurance that the volatility will lessen. There can be no assurance that the closing level of each underlier will be greater than or equal to its coupon barrier level on any observation date so that you will receive a contingent coupon with respect to the applicable interest period, or that the final level of each underlier will be greater than or equal to its downside threshold level so that you do not suffer a significant loss on your initial investment in the securities.

The securities are subject to our credit risk, and any actual or anticipated changes to our credit ratings or credit spreads may adversely affect the market value of the securities. You are dependent on our ability to pay all amounts due on the securities, and, therefore, you are subject to our credit risk. The securities are not guaranteed by any other entity. If we default on our obligations under the securities, your investment would be at risk and you could lose some or all of your investment. As a result, the market value of the securities prior to maturity will be affected by changes in the market’s view of our creditworthiness. Any actual or anticipated decline in our credit ratings or increase in the credit spreads charged by the market for taking our credit risk is likely to adversely affect the market value of the securities.

As a finance subsidiary, MSFL has no independent operations and will have no independent assets. As a finance subsidiary, MSFL has no independent operations beyond the issuance and administration of its securities and will have no independent assets available for distributions to holders of MSFL securities if they make claims in respect of such securities in a bankruptcy, resolution or similar proceeding. Accordingly, any recoveries by such holders will be limited to those available under the related guarantee by Morgan Stanley and that guarantee will rank pari passu with all other unsecured, unsubordinated obligations of Morgan Stanley. Holders will have recourse only to a single claim against Morgan Stanley and its assets under the guarantee. Holders of securities issued by MSFL should accordingly assume that in any such proceedings they would not have any priority over and should be treated pari passu with the claims of other unsecured, unsubordinated creditors of Morgan Stanley, including holders of Morgan Stanley-issued securities.

The rate we are willing to pay for securities of this type, maturity and issuance size is likely to be lower than the rate implied by our secondary market credit spreads and advantageous to us. Both the lower rate and the inclusion of costs associated with issuing, selling, structuring and hedging the securities in the original issue price reduce the economic terms of the securities, cause the estimated value of the securities to be less than the original issue price and will adversely affect secondary market prices. Assuming no change in market conditions or any other relevant factors, the prices, if any, at which dealers, including MS & Co., may be willing to purchase the securities in secondary market transactions will likely be significantly lower than the original issue price, because secondary market prices will exclude the issuing, selling, structuring and hedging-related costs that are included in the original issue price and borne by you and because the secondary market prices will reflect our secondary market credit spreads and the bid-offer spread that any dealer would charge in a secondary market transaction of this type as well as other factors.

The inclusion of the costs of issuing, selling, structuring and hedging the securities in the original issue price and the lower rate we are willing to pay as issuer make the economic terms of the securities less favorable to you than they otherwise would be.

However, because the costs associated with issuing, selling, structuring and hedging the securities are not fully deducted upon issuance, to the extent that MS & Co. may buy or sell the securities in the secondary market during the amortization period specified herein, absent changes in market conditions, including those related to the underliers, and to our secondary market credit spreads, it would do so based on values higher than the estimated value, and we expect that those higher values will also be reflected in your brokerage account statements.

The estimated value of the securities is determined by reference to our pricing and valuation models, which may differ from those of other dealers and is not a maximum or minimum secondary market price. These pricing and valuation models are proprietary and rely in part on subjective views of certain market inputs and certain assumptions about future events, which may prove to be incorrect. As a result, because there is no market-standard way to value these types of securities, our models may yield a higher estimated value of the securities than those generated by others, including other dealers in the market, if they attempted to value the securities. In addition, the estimated value on the pricing date does not represent a minimum or maximum

 Page 10

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

price at which dealers, including MS & Co., would be willing to purchase your securities in the secondary market (if any exists) at any time. The value of your securities at any time after the date of this document will vary based on many factors that cannot be predicted with accuracy, including our creditworthiness and changes in market conditions. See also “The market price of the securities may be influenced by many unpredictable factors” above.

The securities will not be listed on any securities exchange and secondary trading may be limited. The securities will not be listed on any securities exchange. Therefore, there may be little or no secondary market for the securities. MS & Co. may, but is not obligated to, make a market in the securities and, if it once chooses to make a market, may cease doing so at any time. When it does make a market, it will generally do so for transactions of routine secondary market size at prices based on its estimate of the current value of the securities, taking into account its bid/offer spread, our credit spreads, market volatility, the notional size of the proposed sale, the cost of unwinding any related hedging positions, the time remaining to maturity and the likelihood that it will be able to resell the securities. Even if there is a secondary market, it may not provide enough liquidity to allow you to trade or sell the securities easily. Since other broker-dealers may not participate significantly in the secondary market for the securities, the price at which you may be able to trade your securities is likely to depend on the price, if any, at which MS & Co. is willing to transact. If, at any time, MS & Co. were to cease making a market in the securities, it is likely that there would be no secondary market for the securities. Accordingly, you should be willing to hold your securities to maturity.

As discussed in more detail in the accompanying product supplement, investing in the securities is not equivalent to investing in the underlier(s).

The U.S. federal income tax consequences of an investment in the securities are uncertain. There is no direct legal authority regarding the proper U.S. federal income tax treatment of the securities, and significant aspects of the tax treatment of the securities are uncertain. Moreover, non-U.S. investors should note that persons having withholding responsibility in respect of the securities are, absent an exception, expected to withhold on any coupon paid to a non-U.S. investor, generally at a rate of 30%. We will not pay any additional amounts in respect of such withholding. You should review carefully the section entitled “United States Federal Income Tax Considerations” herein, in combination with the section entitled “United States Federal Income Tax Considerations” in the accompanying product supplement, and consult your tax adviser regarding the U.S. federal income tax consequences of an investment in the securities.

Risks Relating to the Underlier(s)

Because your return on the securities will depend upon the performance of the underlier(s), the securities are subject to the following risk(s), as discussed in more detail in the accompanying product supplement.

oYou are exposed to the price risk of each underlier.

oBecause the securities are linked to the performance of the worst performing underlier, you are exposed to a greater risk of not receiving a positive return on the securities and/or sustaining a significant loss on your investment than if the securities were linked to just one underlier.

oWe have no affiliation with any underlying stock issuer.

oWe may engage in business with or involving any underlying stock issuer without regard to your interests.

oThe anti-dilution adjustments the calculation agent is required to make do not cover every corporate event that could affect an underlying stock.

Risks Relating to Conflicts of Interest

In engaging in certain activities described below and as discussed in more detail in the accompanying product supplement, our affiliates may take actions that may adversely affect the value of and your return on the securities, and in so doing they will have no obligation to consider your interests as an investor in the securities.

The calculation agent, which is a subsidiary of Morgan Stanley and an affiliate of MSFL, will make determinations with respect to the securities. As calculation agent, MS & Co. will make any determinations necessary to calculate any payment(s) on the securities. Moreover, certain determinations made by MS & Co., in its capacity as calculation agent, may require it to exercise discretion and make subjective judgments, which may adversely affect your return on the securities. In addition, MS & Co. has determined the estimated value of the securities on the pricing date.

Hedging and trading activity by our affiliates could potentially adversely affect the value of the securities.

 Page 11

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

Historical Information

Bank of America Corporation Overview

Bloomberg Ticker Symbol: BAC

Bank of America Corporation is a bank holding company and a financial holding company. The underlier is registered under the Securities Exchange Act of 1934, as amended. Information provided to or filed with the Securities and Exchange Commission by the underlying stock issuer pursuant to the Securities Exchange Act of 1934, as amended, can be located by reference to Securities and Exchange Commission file number 001-06523 through the Securities and Exchange Commission’s website at www.sec.gov. In addition, information regarding the underlying stock issuer may be obtained from other sources including, but not limited to, press releases, newspaper articles and other publicly disseminated documents. Neither we nor the agent makes any representation that such publicly available documents or any other publicly available information regarding the underlying stock issuer is accurate or complete.

The closing level of the BAC Stock on July 7, 2025 was $48.66. The following graph sets forth the daily closing levels of the underlier for the period noted below. We obtained the historical information presented in this document from Bloomberg Financial Markets, without independent verification. The underlier has at times experienced periods of high volatility. You should not take the historical closing levels of the underlier as an indication of its future performance, and no assurance can be given as to the closing level of the underlier at any time.

BAC Stock Daily Closing Levels

January 1, 2020 to July 7, 2025

 

This document relates only to the securities referenced hereby and does not relate to the underlier or other securities of the underlying stock issuer. We have derived all disclosures contained in this document regarding the underlier from the publicly available documents described above. In connection with this offering of securities, neither we nor the agent has participated in the preparation of such documents or made any due diligence inquiry with respect to the underlying stock issuer. Neither we nor the agent makes any representation that such publicly available documents or any other publicly available information regarding the underlying stock issuer is accurate or complete. Furthermore, we cannot give any assurance that all events occurring prior to the date hereof (including events that would affect the accuracy or completeness of the publicly available documents described above) that would affect the trading price of the underlier (and therefore the closing level of the underlier on the strike date) have been publicly disclosed. Subsequent disclosure of any such events or the disclosure of or failure to disclose material future events concerning the underlying stock issuer could affect the value received with respect to the securities and therefore the value of the securities.

Neither we nor any of our affiliates makes any representation to you as to the performance of the underlier.

 Page 12

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

The Goldman Sachs Group, Inc. Overview

Bloomberg Ticker Symbol: GS

The Goldman Sachs Group, Inc. is a financial institution that delivers financial services to a client base that includes corporations, financial institutions, governments and individuals. The underlier is registered under the Securities Exchange Act of 1934, as amended. Information provided to or filed with the Securities and Exchange Commission by the underlying stock issuer pursuant to the Securities Exchange Act of 1934, as amended, can be located by reference to Securities and Exchange Commission file number 001-14965 through the Securities and Exchange Commission’s website at www.sec.gov. In addition, information regarding the underlying stock issuer may be obtained from other sources including, but not limited to, press releases, newspaper articles and other publicly disseminated documents. Neither we nor the agent makes any representation that such publicly available documents or any other publicly available information regarding the underlying stock issuer is accurate or complete.

The closing level of the GS Stock on July 7, 2025 was $710.93. The following graph sets forth the daily closing levels of the underlier for the period noted below. We obtained the historical information presented in this document from Bloomberg Financial Markets, without independent verification. The underlier has at times experienced periods of high volatility. You should not take the historical closing levels of the underlier as an indication of its future performance, and no assurance can be given as to the closing level of the underlier at any time.

GS Stock Daily Closing Levels

January 1, 2020 to July 7, 2025

 

This document relates only to the securities referenced hereby and does not relate to the underlier or other securities of the underlying stock issuer. We have derived all disclosures contained in this document regarding the underlier from the publicly available documents described above. In connection with this offering of securities, neither we nor the agent has participated in the preparation of such documents or made any due diligence inquiry with respect to the underlying stock issuer. Neither we nor the agent makes any representation that such publicly available documents or any other publicly available information regarding the underlying stock issuer is accurate or complete. Furthermore, we cannot give any assurance that all events occurring prior to the date hereof (including events that would affect the accuracy or completeness of the publicly available documents described above) that would affect the trading price of the underlier (and therefore the closing level of the underlier on the strike date) have been publicly disclosed. Subsequent disclosure of any such events or the disclosure of or failure to disclose material future events concerning the underlying stock issuer could affect the value received with respect to the securities and therefore the value of the securities.

Neither we nor any of our affiliates makes any representation to you as to the performance of the underlier.

 Page 13

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

JPMorgan Chase & Co. Overview

Bloomberg Ticker Symbol: JPM

JPMorgan Chase & Co. is a financial holding company. The underlier is registered under the Securities Exchange Act of 1934, as amended. Information provided to or filed with the Securities and Exchange Commission by the underlying stock issuer pursuant to the Securities Exchange Act of 1934, as amended, can be located by reference to Securities and Exchange Commission file number 001-05805 through the Securities and Exchange Commission’s website at www.sec.gov. In addition, information regarding the underlying stock issuer may be obtained from other sources including, but not limited to, press releases, newspaper articles and other publicly disseminated documents. Neither we nor the agent makes any representation that such publicly available documents or any other publicly available information regarding the underlying stock issuer is accurate or complete.

The closing level of the JPM Stock on July 7, 2025 was $291.97. The following graph sets forth the daily closing levels of the underlier for the period noted below. We obtained the historical information presented in this document from Bloomberg Financial Markets, without independent verification. The underlier has at times experienced periods of high volatility. You should not take the historical closing levels of the underlier as an indication of its future performance, and no assurance can be given as to the closing level of the underlier at any time.

JPM Stock Daily Closing Levels

January 1, 2020 to July 7, 2025

 

This document relates only to the securities referenced hereby and does not relate to the underlier or other securities of the underlying stock issuer. We have derived all disclosures contained in this document regarding the underlier from the publicly available documents described above. In connection with this offering of securities, neither we nor the agent has participated in the preparation of such documents or made any due diligence inquiry with respect to the underlying stock issuer. Neither we nor the agent makes any representation that such publicly available documents or any other publicly available information regarding the underlying stock issuer is accurate or complete. Furthermore, we cannot give any assurance that all events occurring prior to the date hereof (including events that would affect the accuracy or completeness of the publicly available documents described above) that would affect the trading price of the underlier (and therefore the closing level of the underlier on the strike date) have been publicly disclosed. Subsequent disclosure of any such events or the disclosure of or failure to disclose material future events concerning the underlying stock issuer could affect the value received with respect to the securities and therefore the value of the securities.

Neither we nor any of our affiliates makes any representation to you as to the performance of the underlier.

 

 Page 14

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

Additional Terms of the Securities

Please read this information in conjunction with the terms on the cover of this document.

Additional Terms:

If the terms described herein are inconsistent with those described in the accompanying product supplement or prospectus, the terms described herein shall control.

Denominations:

$1,000 per security and integral multiples thereof

Day-count convention:

Interest will be computed on the basis of a 360-day year of twelve 30-day months.

Interest period:

The period from and including the original issue date (in the case of the first interest period) or the previous scheduled coupon payment date, as applicable, to but excluding the following scheduled coupon payment date, with no adjustment for any postponement thereof.

Underlying stock issuer:

With respect to the BAC Stock, Bank of America Corporation

With respect to the GS Stock, The Goldman Sachs Group, Inc.

With respect to the JPM Stock, JPMorgan Chase & Co.

Amortization period:

The 6-month period following the issue date

Trustee:

The Bank of New York Mellon

Calculation agent:

Morgan Stanley & Co. LLC (“MS & Co.”)

 Page 15

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

Additional Information About the Securities

Additional Information:

Minimum ticketing size:

$1,000 / 1 security

United States federal income tax considerations:

You should review carefully the section in the accompanying product supplement entitled “United States Federal Income Tax Considerations.” The following discussion, when read in combination with that section, constitutes the full opinion of our counsel, Davis Polk & Wardwell LLP, regarding the material U.S. federal income tax consequences of owning and disposing of the securities.

Generally, this discussion assumes that you purchased the securities for cash in the original issuance at the stated issue price and does not address other circumstances specific to you, including consequences that may arise due to any other investments relating to an underlier. You should consult your tax adviser regarding the effect any such circumstances may have on the U.S. federal income tax consequences of your ownership of a security.

In the opinion of our counsel, which is based on current market conditions, it is reasonable to treat the securities for U.S. federal income tax purposes as prepaid financial contracts with associated coupons, and any coupons as ordinary income, as described in the section entitled “United States Federal Income Tax Considerations—Tax Consequences to U.S. Holders—Securities Treated as Prepaid Financial Contracts with Associated Coupons” in the accompanying product supplement. There is uncertainty regarding this treatment, and the IRS or a court might not agree with it. Moreover, because this treatment of the securities and our counsel’s opinion are based on market conditions as of the date of this preliminary pricing supplement, each is subject to confirmation on the pricing date. A different tax treatment could be adverse to you.

We do not plan to request a ruling from the IRS regarding the treatment of the securities. An alternative characterization of the securities could materially and adversely affect the tax consequences of ownership and disposition of the securities, including the timing and character of income recognized. In particular, there is a risk that the securities could be characterized as debt instruments for U.S. federal income tax purposes, in which case the tax consequences of an investment in the securities could be different from those described herein and possibly adverse to certain investors. In addition, the U.S. Treasury Department and the IRS have requested comments on various issues regarding the U.S. federal income tax treatment of “prepaid forward contracts” and similar financial instruments and have indicated that such transactions may be the subject of future regulations or other guidance. Furthermore, members of Congress have proposed legislative changes to the tax treatment of derivative contracts. Any legislation, Treasury regulations or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences of an investment in the securities, possibly with retroactive effect.

Non-U.S. Holders. The U.S. federal income tax treatment of the coupons is unclear. To the extent that we have withholding responsibility in respect of the securities, we would expect generally to treat the coupons paid to Non-U.S. Holders (as defined in the accompanying product supplement) as subject to U.S. withholding tax. Moreover, you should expect that, if the applicable withholding agent determines that withholding tax should apply, it will be at a rate of 30% (or lower treaty rate). In order to claim an exemption from, or a reduction in, the 30% withholding under an applicable treaty, you may need to comply with certification requirements to establish that you are not a U.S. person and are eligible for such an exemption or reduction under an applicable tax treaty. You should consult your tax adviser regarding the tax treatment of the coupons.

As discussed under “United States Federal Income Tax Considerations—Tax Consequences to Non-U.S. Holders—Dividend Equivalents under Section 871(m) of the Code” in the accompanying product supplement, Section 871(m) of the Internal Revenue Code and Treasury regulations promulgated thereunder (“Section 871(m)”) generally impose a 30% withholding tax on dividend equivalents paid or deemed paid to Non-U.S. Holders with respect to certain financial instruments linked to U.S. equities or indices that include U.S. equities. The Treasury regulations, as modified by an IRS notice, exempt financial instruments issued prior to January 1, 2027 that do not have a “delta” of one. Based on certain determinations made by us, we expect that Section 871(m) will not apply to the securities with regard to Non-U.S. Holders. Our determination is not binding on the IRS, and the IRS may disagree with this determination. If necessary, further information regarding the potential application of Section 871(m) will be provided in the final pricing supplement for the securities.

We will not be required to pay any additional amounts with respect to U.S. federal withholding taxes.

You should consult your tax adviser regarding the U.S. federal income tax consequences of an investment in the securities, including possible alternative treatments, as well as tax consequences arising under the laws of any state, local or non-U.S. taxing jurisdiction.

 Page 16

Morgan Stanley Finance LLC

Contingent Income Memory Auto-Callable Securities

Principal at Risk Securities

 

Additional considerations:

Client accounts over which Morgan Stanley, Morgan Stanley Wealth Management or any of their respective subsidiaries have investment discretion are not permitted to purchase the securities, either directly or indirectly.

Supplemental information regarding plan of distribution; conflicts of interest:

Selected dealers and their financial advisors will collectively receive from the agent, MS & Co., a fixed sales commission of $ for each security they sell.

MS & Co. is an affiliate of MSFL and a wholly owned subsidiary of Morgan Stanley, and it and other affiliates of ours expect to make a profit by selling, structuring and, when applicable, hedging the securities.

MS & Co. will conduct this offering in compliance with the requirements of FINRA Rule 5121 of the Financial Industry Regulatory Authority, Inc., which is commonly referred to as FINRA, regarding a FINRA member firm’s distribution of the securities of an affiliate and related conflicts of interest. MS & Co. or any of our other affiliates may not make sales in this offering to any discretionary account. See “Plan of Distribution (Conflicts of Interest)” and “Use of Proceeds and Hedging” in the accompanying product supplement.

Where you can find more information:

Morgan Stanley and MSFL have filed a registration statement (including a prospectus, as supplemented by the product supplement) with the Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates. You should read the prospectus in that registration statement, the product supplement and any other documents relating to this offering that MSFL and Morgan Stanley have filed with the SEC for more complete information about Morgan Stanley and this offering. You may get these documents without cost by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, MSFL, Morgan Stanley, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and the product supplement if you so request by calling toll-free 1-(800)-584-6837.

Terms used but not defined in this document are defined in the product supplement or in the prospectus. Each of the product supplement and the prospectus can be accessed via the hyperlinks set forth on the cover of this document.

 

 Page 17

FAQ

What is the maximum return on UBS’s Capped Market-Linked Notes (symbol WUCT 424B2)?

The notes cap upside at 11.75 %, delivering a maximum payment of $1,117.50 per $1,000 note at maturity.

How long is the investment term for the UBS notes?

The expected term is approximately 15 months: trade date 1 Aug 2025; maturity date 5 Nov 2026.

What happens if one of the indices declines?

If the least-performing index is flat or negative, investors receive only their $1,000 principal; no positive return is paid.

Are the notes insured or secured?

No. They are unsecured, unsubordinated debt of UBS AG. Repayment depends on UBS’s creditworthiness.

Will there be a secondary market for these structured notes?

UBS Securities LLC may make markets, but the notes will not be listed; liquidity is therefore limited and prices may be below theoretical value.

Why does the estimated initial value differ from the $1,000 issue price?

The $962.30�$992.30 estimate reflects underwriting fees, hedging and funding costs, meaning investors pay a premium over model value at issuance.

How are the notes treated for U.S. tax purposes?

UBS expects them to be contingent payment debt instruments, requiring holders to accrue original issue discount annually.
Morgan Stanley

NYSE:MS

MS Rankings

MS Latest News

MS Latest SEC Filings

MS Stock Data

225.98B
1.22B
23.64%
62.12%
0.89%
Capital Markets
Security Brokers, Dealers & Flotation Companies
United States
NEW YORK